Inoviem Scientific

About:

CRO offering preclinical & clinical services via its innovative label-free technologies for translational drug discovery and development

Website: http://www.inoviem.com

Top Investors: Cap Innov'Est

Description:

Inoviem Scientific is a privately-owned contract research biotech (CRB) offering preclinical and clinical services that use cutting-edge proprietary technologies to speed up drug-development. Our pioneering technologies allow us to work in any therapeutic field and with any therapeutic compound (small chemical molecules, fragments, proteins, peptides, antibodies, etc). Our clients are any laboratories in the private or academic sphere working to develop therapeutic compounds. Our innovatory force lies with the technologies we have developed, and our strength generally resides in our ability to analyse drug-target interaction to a high degree of precision directly on crude human tissue, thus respecting physiological conditions. Our goal is to be your partner of choice for the development of drug candidates. Our technologies have the potential to bring to light information hidden within crude human tissue obtained from patients or healthy donors. Their use will significantly improve your chances of marketing your drug. As a technollogy and innovation driven CRB, Inoviem Scientific is continuously investing human and financial resources in the development of complementary technologies to bring the best technological, creative and innovative solutions to its clients. This continuous investment will reinforce our analysis power driving Inoviem Scientific to become: From preclinical to clinical: A leading explorer of drug-target interaction!